ALLR News and Press, Allarity Therapeutics Inc. From 10/11/22

Allarity Therapeutics press release ( NASDAQ: ALLR ): Q2 GAAP EPS of -$0.72 misses by $0.46 . As of June 30, 2022, Allarity’s cash was $7.7 million, as compared to $19.6 million as of December 31, 2021 Shares +4.07% . For further details see: A...

Cambridge, MA U.S.A. ( October 11 , 2022) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP ® companion diagn...

Press release Cambridge, MA U.S.A. (September 26, 2022) — Allarity Therapeutics, Inc. (Nasdaq: ALLR) (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP &#x...

Press release Cambridge, MA U.S.A. (September 16, 2022) — Allarity Therapeutics, Inc. (Nasdaq: ALLR) (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP &#x...

Press release Cambridge, MA U.S.A. (September 12, 2022) — Allarity Therapeutics, Inc. (Nasdaq: ALLR) (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP ...

Allarity Therapeutics ( NASDAQ: ALLR ) received Nasdaq notice on August 23, 2022 as the company was not in compliance. Company failed to file its quarterly report for quarter ended  June 30, 2022 with SEC. Company has 60 calendar days to submit to Nasdaq a p...

Allarity Therapeutics press release ( NASDAQ: ALLR ): Q2 GAAP EPS of -$0.52 misses by $0.07 . The company has incurred significant losses and has an accumulated deficit of $74.2M as of June 30, 2022. The company had no cash equivalents or restricted cash on June 30...

Bed Bath & Beyond BBBY -43% after RC Ventures cuts entire stake ; taps restructuring lawyers for help with debt - Bloomberg Capstone Green Energy CGRN -41% after pricing ~$8M securities offering . Lizhi LIZI -18% on Q2 earnings release . Vin...

Gainers: Curis ( CRIS ) +36% . Allarity Therapeutics ( ALLR ) +23% . Codiak BioSciences ( CDAK ) +21% . Cassava Sciences ( SAVA ) +17% .  AlerisLife ( ALR ) +11% . Losers: Blue Water Vaccines ( BWV ) -27% ...

Clinical-stage biotech Allarity Therapeutics ( NASDAQ: ALLR ) announced on Tuesday that its board decided to reprioritize the company’s pipeline strategy towards the advancement of combination therapies and move away from the development of monotherapies.  Allarity (...